AR121189A2 - ANTI-TIGIT ANTIBODIES AND METHODS OF USE - Google Patents

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

Info

Publication number
AR121189A2
AR121189A2 ARP210100111A ARP210100111A AR121189A2 AR 121189 A2 AR121189 A2 AR 121189A2 AR P210100111 A ARP210100111 A AR P210100111A AR P210100111 A ARP210100111 A AR P210100111A AR 121189 A2 AR121189 A2 AR 121189A2
Authority
AR
Argentina
Prior art keywords
methods
tigit antibodies
tigit
antibodies
domained
Prior art date
Application number
ARP210100111A
Other languages
Spanish (es)
Inventor
Jane L Grogan
Robert J Johnston
Yan Wu
Wei Liang
- Lupardus Patrick Ching
Mahesh Yadav
Dhaya Seshasayee
Meredith Hazen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AR121189A2 publication Critical patent/AR121189A2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente se refiere a anticuerpos anti-TIGIT (inmunoreceptor de células T con dominios de Ig e ITIM) y métodos de uso de los mismos.The present relates to anti-TIGIT (Ig- and ITIM-domained T-cell immunoreceptor) antibodies and methods of use thereof.

ARP210100111A 2015-09-25 2021-01-18 ANTI-TIGIT ANTIBODIES AND METHODS OF USE AR121189A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562233230P 2015-09-25 2015-09-25

Publications (1)

Publication Number Publication Date
AR121189A2 true AR121189A2 (en) 2022-04-27

Family

ID=60931770

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP160102929A AR106146A1 (en) 2015-09-25 2016-09-26 ANTI-TIGIT ANTIBODIES AND METHODS OF USE
ARP210100111A AR121189A2 (en) 2015-09-25 2021-01-18 ANTI-TIGIT ANTIBODIES AND METHODS OF USE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP160102929A AR106146A1 (en) 2015-09-25 2016-09-26 ANTI-TIGIT ANTIBODIES AND METHODS OF USE

Country Status (1)

Country Link
AR (2) AR106146A1 (en)

Also Published As

Publication number Publication date
AR106146A1 (en) 2017-12-13

Similar Documents

Publication Publication Date Title
CL2018000595A1 (en) Anti-PD1 antibodies and methods of use
CL2019002824A1 (en) Anti-lag3 antibodies.
ECSP18007905A (en) MONOCLONAL ANTIBODIES AGAINST BCMA
ZA201900857B (en) Anti-tigit antibodies and methods of use
CO2017013351A2 (en) Cot modulators and methods of using them
CL2020002540A1 (en) Anti-hla-g antibodies and their use
CR20150618A (en) ANTITRANSPHERINE RECEIVING ANTIBODIES AND METHODS OF USE
CO2018000244A2 (en) Affinity-matured and humanized antibodies to fcrh5
ECSP18000844A (en) TAU UNION ANTIBODIES
CL2016002455A1 (en) Multispecific antibodies.
CL2017001361A1 (en) Heterodimeric antibodies that bind to cd3 and cd38
BR112015032224A2 (en) anti-fcrh5 antibodies
CR20160500A (en) ANTI-OX40 ANTIBODIES AND METHODS OF USE
CO2017006740A2 (en) Anti-cd79b antibodies
CL2018000479A1 (en) Lymphoopeitin strimal tomica (tslp) - binding antibodies and methods of antibody use
CU20170074A7 (en) HETERODIMERIC ANTIBODIES THAT JOIN CD3 AND TUMOR ANTIGENS
BR112017011932A8 (en) ANTIBODIES TARGETED TO G-PROTEIN COUPLED RECEPTOR AND METHODS OF USE
BR112017023943A2 (en) cd3-binding heterodimeric antibodies and tumor antigens
PE20181005A1 (en) BISPECIFIC ANTIBODIES AGAINST THE HUMAN A- BETA AND THE HUMAN TRANSFERRIN RECEPTOR AND METHODS OF USE
PE20210648A1 (en) ANTI-CD3 ANTIBODIES AND METHODS OF USE
ECSP18000887A (en) TAU UNION ANTIBODIES
BR112017009297A2 (en) humanized c1q complement antifactor antibodies and uses thereof
CO2020012360A2 (en) Multispecific antibodies and their use
CR20160270A (en) ANTI-TAU ANTIBODIES (pS422) HUMANIZED AND USED METHODS
CL2018001139A1 (en) Anti-htra1 antibodies and methods of use thereof.